Latest Breaking News On - Tern chief executive officer - Page 1 : comparemela.com

Terns Pharmaceuticals Announces Leadership Transition

FOSTER CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to

Mark vignolaSenthil sundaramCompany nasdaqHead of research development at ternsTerns pharmaceuticals incHead of research developmentBerry company public relationsPeritoneal cancer foundationTerns pharmaceuticalsTern chief executive officerSenior advisorErin quirkInitial public offeringDavid fellowsWestern presidentChief medical officer

Terns Pharmaceuticals Announces Leadership Transition

Senthil Sundaram Stepping Down as Chief Executive Officer for Health Reasons.

Senthil sundaramMark vignolaHead of research developmentHead of research development at ternsBerry company public relationsPeritoneal cancer foundationCompany nasdaqTerns pharmaceuticalsTerns pharmaceuticals incTern chief executive officerSenior advisorErin quirkInitial public offeringDavid fellowsWestern presidentChief medical officer

Terns Pharmaceuticals (TERN) Announces CEO Transition

Terns Pharmaceuticals (TERN) Announces CEO Transition
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Senthil sundaramTerns pharmaceuticals incHead of research development at ternsPeritoneal cancer foundationHead of research developmentTerns pharmaceuticalsTern chief executive officerSenior advisorErin quirkInitial public offeringDavid fellowsWestern presidentChief medical officer

Terns Pharmaceuticals Announces Leadership Transition

Terns Pharmaceuticals Announces Leadership Transition
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Senthil sundaramMark vignolaCompany nasdaqHealth reasonsPeritoneal cancer foundationHead of research development at ternsTerns pharmaceuticals incHead of research developmentTerns pharmaceuticalsBerry company public relationsSenthil sundaram stepping downChief executive officerTern chief executive officerSenior advisorErin quirkInitial public offering

Terns Pharmaceuticals Announces Leadership Transition

Senthil sundaramMark vignolaTerns pharmaceuticalsTerns pharmaceuticals incHead of research developmentCompany nasdaqHead of research development at ternsPeritoneal cancer foundationHealth reasonsBerry company public relationsSenthil sundaram stepping downChief executive officerTern chief executive officerSenior advisorErin quirkInitial public offering